Economic evaluation of HIV treatments: The I.CO.N.A. cohort study

Health Policy

Volumn 74, Issue 3, 2005, Pages 304-313

  Merito, Monica ^a   Bonaccorsi, Andrea ^a   Pammolli, Fabio ^b   Riccaboni, Massimo ^b   Baio, Gianluca ^b   Arici, Claudio ^c   D'Arminio Monforte, Antonella ^d   Pezzotti, Patrizio ^e   Corsini, Dario ^f   Tramarin, Andrea ^g   Cauda, Roberto ^e,h   Colangeli, Vincenzo ⁱ   Pastore, Giuseppe ^j   Montroni, M ^k   Scalise, G ^k   Braschi, M C ^k   Del Prete, M S ^k   Tirelli, U ^k   Cinelli, R ^k   Ladisa, N ^j   Minafra, G ^j   Suter, F ^c   Chiodo, F ⁱ   Fiorini, C ⁱ   Coronado, O ⁱ   Carosi, G ^k   Cadeo, G P ^k   Torti, C ^k   Minardi, C ^k   Bertelli, D ^k   Rizzardini, G ^k   Migliorino, G ^k   Manconi, P E ^k   Piano, P ^k   Ferraro, T ^k   Scerbo, A ^k   Pizzigallo, E ^k   D'Alessandro, M ^k   Santoro, D ^k   Pusterla, L ^k   Carnevale, G ^k   Galloni, D ^k   Vigano P ^l   Mena, M ^l   Ghinelli, F ^k   Sighinolfi, L ^k   Leoncini, F ^k   Mazzotta, F ^k   Pozzi, M ^k   Lo Caputo, S ^k   Angarano, G ^k   Grisorio, B ^k   Saracino, A ^k   Ferrara, S ^k   Grima, P ^m   Tundo, P ^m   Pagano, G ^k   Cassola, G ^k   Alessandrini, A ^k   Piscopo, R ^k   Toti, M ^k   Chigiotti, S ^k   Soscia, F ^k   Tacconi, L ^k   Orani, A ^k   Perini, P ^k   Scasso, A ^k   Vincenti, A ^k   Chiodera, F ^k   Castelli, P ^k   Scalzini, A ^k   Fibbia, G ^k   Moroni, M ^d   Lazzarin, A ^d   Cargnel, A ^d   Vigevani, G M ^d   Caggese, L ^d   Repetto, D ^d   Novati, R ^d   Galli, A ^d   Merli, S ^d   Pastecchia, C ^d   Moioli, M C ^d   Esposito, R ^k   Mussini, C ^k   Abrescia, N ^k   Chirianni, A ^k   Izzo, C M ^k   Piazza, M ^k   De Marco, M ^k   Viglietti, R ^k   Manzillo, E ^k   Graf, M ^k   Colomba, A ^k   Abbadessa, V ^k   Prestileo, T ^k   Mancuso, S ^k   Ferrari, C ^k   Pizzaferri, P ^k   Filice, G ^k   Minoli, L ^k   Bruno, R ^k   Novati, S ^k   Baldelli, F ^k   Tinca, M ^k   Petrelli, E ^k   Cioppi, A ^k   Alberici, F ^k   Ruggieri, A ^k   Menichetti, F ^a   Martinelli, C ^a   De Stefano, C ^k   La Gala, A ^k   Ballardini, G ^k   Briganti, E ^k   Magnani, G ^k   Ursitti, M A ^k   Arlotti, M ^k   Ortolani, P ^k   Dianzani, F ^e   Ippolito, G ^e   Antinori, A ^e   Antonucci, G ^e   D'Elia, S ^e   Narciso, P ^e   Petrosillo, N ^e   Vullo, V ^e   De Luca, A ^e   Di Giambenedetti, S ^e   Zaccarelli, M ^e   Acinapura, R ^e   De Longis, P ^e   Ciardi, M ^e   D'Offizi, G ^e   Trotta, M P ^e   Noto, P ^e   Lichtner, M ^e   Capobianchi, M R ^e   Girardi, E ^e   Rezza, G ^e   Mura, M S ^k   Mannazzu, M ^k   Resta, F ^k   Loso, K ^k   Caramello, P ^k   Sinicco, A ^k   Soranzo, M L ^k   Orofino, G ^k   Sciandra, M ^k   Bonasso, M ^k   Grossi, P A ^k   Basilico, C ^k   Poggio, A ^k   Bottari, G ^k   Raise, E ^k   Pasquinucci, S ^k   De Lalla, F ^g   Tositti, G ^g   Lepri, A Cozzi ⁿ   more..

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f Informasrl   (Italy)

^g SAN BORTOLO HOSPITAL   (Italy)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j UNIVERSITY OF BARI   (Italy)

^k NONE   (Italy)

^l NONE   (Italy)

^m NONE   (Italy)

ⁿ London Mobile Learning Group   (United Kingdom)

more..

Author keywords

Costs per person year; HAART; Health resources; HIV infection

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ECONOMIC EVALUATION; FOLLOW UP; HEALTH CARE COST; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; NATIONAL HEALTH SERVICE;

EID: 26844520063     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2005.01.016     Document Type: Article

References (24)

1. S.M. Hammer, K.E. Squires, and M.D. Hughes A controlled trial of two nucleoside analogues plus Indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less New England Journal of Medicine 337 11 1997 725 733
2. J.S.G. Montaner, P. Reiss, and D. Cooper A randomised, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients The INCAS Trial Journal of the American Medical Association 279 12 1998 930 937
3. F.J. Palella Jr., K.M. Delaney, and A.C. Moorman Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection New England Journal of Medicine 338 13 1998 853 860
4. A. Mocroft, B. Ledergerber, and C. Katlama Decline in the AIDS and death rates in the EuroSIDA study: an observational study Lancet 362 9377 2003 22 29
5. K. Porter, A. Babiker, and K. Bhaskaran Determinants of survival following HIV-1 seroconversion after the introduction of HAART Lancet 362 9392 2003 1267 1274
6. P. Pezzotti, P.A. Napoli, and S. Acciai Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies Tuscany AIDS Study Group. AIDS 13 2 1999 249 255
7. Y. Mouton, S. Alfandari, and M. Valette Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centers AIDS 11 1997 F101 F105
8. K.A. Gebo, R.E. Chaisson, and J.G. Folkemer Costs of HIV medical care in the era of highly active antiretroviral therapy AIDS 13 1999 963 969
9. S.A. Bozzette, G. Joyce, and D.F. McCaffrey Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy New England Journal of Medicine 344 11 2001 817 823
10. A. d'Arminio Monforte, C. Arici, and G. Ippolito Lo studio di coorte I.CO.N.A. (Italian Cohort Naive Antiretrovirals): caratteristiche all'arruolamento dei primi 1676 soggetti Giornale Italiano dell'AIDS 8 4 1997 119 126
11. Decreto Ministeriale 30/06/1997. Aggiornamento delle tariffe delle prestazioni di assistenza ospedaliera, di cui al decreto ministeriale 14 dicembre 1994 e Tariffe delle prestazioni di riabilitazione ospedaliera erogate in regime di degenza ex D.M. 30.06.1997 espresse in euro. Gazzetta Ufficiale 08/09/1997.
12. Decreto Ministeriale 22/07/1996. Prestazioni di assistenza specialistica ambulatoriale erogabili nell'ambito del SSN e relative tariffe. Gazzetta Ufficiale 14/09/1996.
13. P. Pezzotti, A. d'Arminio Manforte, and R. Bagarini Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values European Journal of Epidemiology 16 2000 919 926
14. A. Cozzi Lepri, A.N. Phillips, and A. d'Arminio Manforte When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the I.CO.N.A. study AIDS 15 2001 983 990
15. M. Dorrucci, M. Balducci, and P. Pezzetti Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: estimates of the population effect of treatment Journal of Acquired Immune Deficiency Syndromes 22 1 1999 65 70
16. D. Porta, E. Rapiti, and F. Forastiere Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998, Lazio AIDS Surveillance Collaborative Group AIDS 13 15 1999 2125 2131
17. P. Pezzotti, M. Dorrucci, and A. Donisi Sopravvivenza, progressione in AIDS e livello di immunosoppressione in persone HIV-positive prima e dopo l'introduzione della terapia antiretrovirale di combinazione con tre o più farmaci (HAART) Epidemiologia e Prevenzione 27 2003 333 339
18. R. Bruno, P. Sacchi, and S.F.A. Patruno HAART (Zidovudina, Lamivudina, Indinavir): analisi dei costi in una popolazione di pazienti HIV positivi con conta linfocitaria CD4+<200/mmc Pharmacoeconomics - Italian Research Articles 1 1 1999 35 41
19. L. Garattini, F. Tediosi, and E. Di Cintio Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy AIDS Care 13 6 2001 733 741
20. A. Tramarin, S. Campostrini, and M.J. Postma A multicenter study of patient survival, disability, quality of life and cost of care. Among patients with AIDS in Northen Italy Pharmacoeconomics 22 1 2004 43 53
21. M. Stoll, C. Claes, and E. Schulte Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART European Journal of Medical Research 7 2002 463 471
22. F. Taroni DRG/ROD e Nuovo Sistema di Finanziamento degli Ospedali Roma: Il Pensiero Scientifico Editore 1996
23. E.J. Beck, A.H. Miners, and K. Tolley The cost of HIV treatment and care. A global review Pharmacoeconomics 19 1 2001 13 39
24. P. Sendi, A.J. Palmer, and A. Gafni Highly active antiretroviral therapy. Pharmacoeconomic issues in the management of HIV infection Pharmacoeconomics 19 7 2001 709 713